Group 1 - The internal investigation focused on sales practices in the United States related to NEXPLANON and two wholesalers, concluding that the primary issue was the "tone at the top" from the CEO's perspective [2] - The investigation has been fully completed, and a detailed remediation plan has been approved by the Audit Committee of the Board [2] - The remediation efforts emphasize the importance of leadership engagement and organizational training to improve practices [3]